199 related articles for article (PubMed ID: 35464363)
1. Phenotypic Characterization of a Virulent PRRSV-1 Isolate in a Reproductive Model With and Without Prior Heterologous Modified Live PRRSV-1 Vaccination.
Kreutzmann H; Stadler J; Knecht C; Sassu EL; Ruczizka U; Zablotski Y; Vatzia E; Balka G; Zaruba M; Chen HW; Riedel C; Rümenapf T; Ladinig A
Front Vet Sci; 2022; 9():820233. PubMed ID: 35464363
[TBL] [Abstract][Full Text] [Related]
2. Influence of PRRSV-1 vaccination and infection on mononuclear immune cells at the maternal-fetal interface.
Stas MR; Kreutzmann H; Stadler J; Sassu EL; Mair KH; Koch M; Knecht C; Stadler M; Dolezal M; Balka G; Zaruba M; Mötz M; Saalmüller A; Rümenapf T; Gerner W; Ladinig A
Front Immunol; 2022; 13():1055048. PubMed ID: 36426366
[TBL] [Abstract][Full Text] [Related]
3. Initial vaccination and revaccination with Type I PRRS 94881 MLV reduces viral load and infection with porcine reproductive and respiratory syndrome virus.
Kroll J; Piontkowski M; Kraft C; Coll T; Gomez-Duran O
Porcine Health Manag; 2018; 4():23. PubMed ID: 30151235
[TBL] [Abstract][Full Text] [Related]
4. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
[TBL] [Abstract][Full Text] [Related]
5. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity of three type 2 porcine reproductive and respiratory syndrome virus strains in experimentally inoculated pregnant gilts.
Ladinig A; Detmer SE; Clarke K; Ashley C; Rowland RR; Lunney JK; Harding JC
Virus Res; 2015 May; 203():24-35. PubMed ID: 25796212
[TBL] [Abstract][Full Text] [Related]
8. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model.
Pileri E; Gibert E; Soldevila F; García-Saenz A; Pujols J; Diaz I; Darwich L; Casal J; Martín M; Mateu E
Vet Microbiol; 2015 Jan; 175(1):7-16. PubMed ID: 25439650
[TBL] [Abstract][Full Text] [Related]
10. Clinical consequences of exposing pregnant gilts to strains of porcine reproductive and respiratory syndrome (PRRS) virus isolated from field cases of "atypical" PRRS.
Mengeling WL; Lager KM; Vorwald AC
Am J Vet Res; 1998 Dec; 59(12):1540-4. PubMed ID: 9858403
[TBL] [Abstract][Full Text] [Related]
11. Variation in fetal outcome, viral load and ORF5 sequence mutations in a large scale study of phenotypic responses to late gestation exposure to type 2 porcine reproductive and respiratory syndrome virus.
Ladinig A; Wilkinson J; Ashley C; Detmer SE; Lunney JK; Plastow G; Harding JC
PLoS One; 2014; 9(4):e96104. PubMed ID: 24756023
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) Vaccine against Experimental Infection with PRRSV AUT15-33 in Weaned Piglets.
Duerlinger S; Knecht C; Sawyer S; Balka G; Zaruba M; Ruemenapf T; Kraft C; Rathkjen PH; Ladinig A
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746542
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate.
Lager KM; Mengeling WL; Brockmeier SL
Am J Vet Res; 1999 Aug; 60(8):1022-7. PubMed ID: 10451216
[TBL] [Abstract][Full Text] [Related]
15. Classification of fetal resilience to porcine reproductive and respiratory syndrome (PRRS) based on temporal viral load in late gestation maternal tissues and fetuses.
Malgarin CM; Nosach R; Novakovic P; Suleman M; Ladinig A; Detmer SE; MacPhee DJ; Harding JCS
Virus Res; 2019 Jan; 260():151-162. PubMed ID: 30529234
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of concurrent vaccination with modified-live PRRSV-1 and PRRSV-2 vaccines against heterologous dual PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Kang I; Park SJ; Chae C
Vet Microbiol; 2019 Dec; 239():108497. PubMed ID: 31767085
[TBL] [Abstract][Full Text] [Related]
18. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
19. Field evaluation of the safety and compatibility of a combined vaccine against porcine parvovirus 1 and porcine reproductive and respiratory syndrome virus in breeding animals.
Garcia-Morante B; Noguera M; Kraft C; Bridger P
Porcine Health Manag; 2019; 5():28. PubMed ID: 31890252
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
